Wells Fargo Starts MEI Pharma (MEIP) at Outperform
Tweet
Share
E-mailGet Alerts MEIP Hot Sheet
Price: $3.25 --0%
Rating Summary:
7 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Rating Summary:
7 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
Wells Fargo initiated coverage on MEI Pharma (NASDAQ: MEIP) with an Outperform rating and a price target of $10-$11. Analyst Matthew Andrews sees the stock as undervalued based on pracinostat's potential in MDS and AML.
For an analyst ratings summary and ratings history on MEI Pharma click here. For more ratings news on MEI Pharma click here.
Shares of MEI Pharma closed at $3.95 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TD Cowen Resumes EQT Corp. (EQT) at Hold
- Northcoast Research Starts Deluxe Corp (DLX) at Buy
- Craig-Hallum Assumes Alimera Sciences (ALIM) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
